Is digital rectal examination still necessary in the early detection of prostate cancer?

Irish Journal of Medical Science

Volumn 176, Issue 3, 2007, Pages 161-163

  Quinlan, Mark R ^a,b   Teahan, S ^a   Mulvin, D ^a   Quinlan, D M ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b NONE   (Ireland)

Author keywords

DRE; Prostate cancer; PSA; TRUS biopsy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CASE REPORT; DIAGNOSTIC VALUE; DIGITAL RECTAL EXAMINATION; EARLY DIAGNOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PROSTATE BIOPSY; PROSTATE CANCER; TRANSRECTAL ULTRASONOGRAPHY; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; DIGITAL RECTAL EXAMINATION; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 34548477908     PISSN: 00211265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11845-007-0018-x     Document Type: Article

References (12)

1. Colberg JW, Smith DS, Catalona WJ (1993) Prevalence and pathological extent of prostate cancer in men with prostate specific antigen levels of 2.9 to 4.0 ng./ml. J Urol 149(3):507-509
2. Brawer Mk (1999) Complexed PSA: The newest advance in PSA testing. Urology 54(1):2-3
3. Oesterling JE (1994) PSA and early prostate cancer detection: The importance of age-specific reference ranges. Can J Oncol 4(Suppl 1):52-56
4. Coley CM, Barry MJ, Fleming C, Mulley AG (1997) Early detection of prostate cancer. Part 1: Prior probability and effectiveness of tests. The American college of physicians. Ann Intern Med 126(5):394-406
5. Candas B, Cusan L, Gomez JL et al (2000) Evaluation of prostate specific antigen and digital rectal examination as screening tests for prostate cancer. Prostate 45(1):19-35
6. Roberts RO, Bergstralh EJ, Lieber MM, Jacobsen SJ (2000) Digital rectal examination and prostate-specific antigen abnormalities at the time of prostate biopsy and biopsy outcomes, 1980 to 1997. Urology 56(5):817-822
7. Ng TK, Vasilareas D, Mitterdorfer AJ, Maher PO, Lalak A (2005) Prostate cancer detection with digital rectal examination, prostate-specific antigen, transrectal ultrasonography and biopsy in clinical urological practice. BJU Int 95(4):545-548
8. Makinen T, Tammela TL, Hakama M et al (2001) Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: A comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests. J Urol 166(4):1339-1342
9. Philip J, Dutta Roy S, Ballal M, Foster CS, Javle P (2005) Is a digital rectal examination necessary in the diagnosis and clinical staging of early prostate cancer? BJU Int 95(7):969-971
10. Thompson IM, Pauler DK, Goodman PJ et al (2004) Prevalence of prostate cancer among men with a prostate-specific antigen level of < or = 4.0 ng per milliliter. N Engl J Med 350(22):2239-2246
11. Nishio R, Furuya Y, Nagakawa O, Fuse H (2003) Metastatic prostate cancer with normal level of serum prostate-specific antigen. Int Urol Nephrol 35(2):189-192
12. Argyropoulos A, Doumas K, Farmakis A, Aristas O, Kontogeorgos G, Lykourinsa M (2005) Characteristics of patients with stage T1b incidental prostate Cancer. Scand J Urol Nephrol 39(4):289-293